Three types of Bloom syndrome B-lymphoblastoid cell lines, as well as one derived from a normal person, treated with 4-nitroquinoline-N-oxide and N-methyl-N'-nitro-N-nitrosoguanidine (0.3 ,jg/ml for 24 hr), were studied for tumorigenicity in nude mice, colony formation in soft agar, cytogenetic changes, and immunoglobulin markers. (11, 13) . Even though the exact biological significance of SCE changes in carcinogenesis and Bloom syndrome is unknown, it seems valuable to study the tumorigenicity in nude mice, colony formation in soft agar, and changes in immunoglobulin as related to the SCE levels in carcinogen-treated Bloom syndrome B-lymphoblastoid cell lines.
When normal and Bloom syndrome cells with normal sister chromatid exchange (SCE) levels and karyotypes (type I) were treated with carcinogens, no significant changes occurred in the immunoglobulin proffle and karyotype, only rare colony formation was seen, and no tumors were produced. In contrast, when Bloom syndrome cells with high SCE levels (type II with normal karyotype and type III with an abnormal karyotype) were treated with carcinogens, tumors were produced in 22 of 53 nude mice injected; a high rate of colony formation in soft agar was seen; the cells exhibited virtual loss of immunoglobulin markers; and structural changes in chromosomes 1, 2, 3, 4, 5, 7, 11, 14, and 15 were found in the tumors in addition to the original chromosome abnormalities present in the injected cells. It appears that Bloom syndrome B-lymphoblastoid cell lines with high levels of SCE are highly susceptible to the action of carcinogens, as evidenced by tumor formation in nude mice and colony formation in agar. Apparently, the carcinogens were capable of transforming only those cells that had a critical level of SCE (=140 per cell) and not those with only mildly increased levels (=13 per cell).
Epstein-Barr virus (EBV) has been widely used to transform B lymphocytes from healthy donors and patients with a variety of diseases (1) (2) (3) . Parallel cytogenetic and nude mouse inoculation studies (4) (5) (6) have recently dispelled the earlier notion that all EBV-immortalized human cell lines are tumorigenic, irrespective of their origin. EBV-immortalized normal human B lymphocytes remained purely diploid during several months of cultivation in vitro, failed to grow subcutaneously in nude mice, and had a low cloning efficiency in agarose (6) . We have previously reported the establishment of several EBV-transformed B-lymphoblastoid cell lines from Bloom syndrome patients (7, 8) , a genetic disease that is characterized by predisposition to cancer and increased sister chromatid exchanges (SCEs) in cells labeled with bromodeoxyuridine (BrdUrd) for two cell cycles (9, 10 (11, 13) . Even though the exact biological significance of SCE changes in carcinogenesis and Bloom syndrome is unknown, it seems valuable to study the tumorigenicity in nude mice, colony formation in soft agar, and changes in immunoglobulin as related to the SCE levels in carcinogen-treated Bloom syndrome B-lymphoblastoid cell lines.
MATERIALS AND METHODS
Cell Lines and Cell Culture. Permanent Bloom syndrome B-lymphoblastoid cell lines (BS2-1, BS2-2, BS-SY1, and BS-SY2) and a normal B-lymphoblastoid cell line (KS86) were established from patients with Bloom syndrome and from a normal subject, respectively, by using EBV (7, 8 The establishment of these two new cell lines was accomplished by a method previously described (7, 8 (17, 18) . Colonies were counted after 3 weeks of culture. In this assay, anchorage-dependent cells have a negligible efficiency of plating-i.e., only transformed qells give rise to colonies in soft agar at the critical agar concentration of 0.3%. Seven days after carcinogen treatment, surface and cytoplasmic immunoglobulin were analyzed (14) . For SCE observations, the cells were labeled with BrdUrd while exposed to it at a concentration of 5.0 ,ug/ml for 48 hr. Chromosome preparations were made according to a routine air-drying method (10) . Differential staining of sister chromatids and karyotype analysis were performed by using the FPG technique (19) and Q-banding, respectively.
Detection of Immunoglobulin and EBV-Related Antigens (EBNA). Lymphoblastoid cells and tumor cells that were excised and suspended by pipetting were washed three times in phosphate-buffered saline. Surface immunoglobulin was tested with fresh cell samples. Cytoplasmic immunoglobulin and EBNA tests were carried out using fixed cell preparations. Surface and cytoplasmic immunoglobulin were tested by direct immunofluorescence with fluorescein isothiocyanate-conjugated goat antisera monospecific for human IgM, IgD, IgG, IgA, and K and X light chains. All these assays were performed as described (14, 15) . The anticomplement immunofluorescence test (20) was performed for the detection of EBNA. In all experiments, EBV-negative serum and known EBNA-negative and EBNA-positive cell lines were Patients with Bloom syndrome have a greatly increased incidence of malignancy. In fact, the bulk of the patients develop leukemia, lymphoma, or cancer at an early age. It is possible that the high SCE levels seen in the cells of these patients may not only reflect a high susceptibility to malignant transformation, but may also be related to the readiness of the cells to undergo such a transformation. An interesting observation in the present study was the disappearance of surface and cytoplasmic Ig in the transformed cells. complicated karotype. The presence ofthese two phenomena was insufficient for this particular cell line to produce tumors, and the cells required an additional event, apparently induced by a carcinogen. This observation, although it may be unique to the experiments performed, may have relevance to conditions in which cells with chromosomal changes and/or high SCE levels exist but do not apparently undergo malignant transformation. In the human, such a situation is not rare in preleukemic states (23) .
